Skip to main content

Table 1 Utilisation of statins, acute myocardial infarction (AMI)-mortality, AMI-incidence and coronary revascularisation rates in Sweden's 289 municipalities' male populations, 1998-2002.

From: No connection between the level of exposition to statins in the population and the incidence/mortality of acute myocardial infarction: An ecological study based on Sweden's municipalities

  Utilisation of statins DDD/TID1
Age/years 1998 1999 2000 2001 2002
40-49 14.0 (2.28-47.5) 18.2 (2.29-49.5) 23.7 (2.46-59.1) 28.0 (1.63-72.0) 32.0 (4.26-75.7)
50-59 43.4 (10.3-114) 58.2 (12.5-182) 78.1 (20.2-184) 95.0 (34.7-222) 111 (42.5-267)
60-69 75.0 (21.1-196) 103 (34.6-267) 139 (43.1-363) 171 (56.8-391) 202 (93.2-400)
70-79 62.1 (5.82-167) 92.1 (14.9-221) 133 (34.2-319) 174 (47.0-384) 218 (71.3-457)
  AMI-mortality/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 0.25(0-3.57) 0.24 (0-4.00) 0.26 (0-6.17) 0.21 (0-2.78) 0.15 (0-3.07)
50-59 0.82 (0-6.05) 0.72 (0-4.67) 0.91 (0-7.50) 0.74 (0-7.25) 0.74 (0-7.14)
60-69 2.94 (0-11.3) 2.65 (0-12.9) 2.58 (0-9.76) 2.36 (0-10.9) 2.40 (0-9.17)
70-79 8.74 (0-24.5) 8.61 (0-24.7) 7.81 (0-25.0) 6.80 (0-23.6) 6.73 (0-24.7)
  AMI-incidence/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 1.60 (0-9.67) 1.49 (0-6.22) 1.37 (0-6.17) 1.39 (0-6.02) 1.33 (0-7.75)
50-59 5.00 (0-20.3) 4.53 (0-15.0) 4.63 (0-15.8) 4.93 (0-21.7) 4.63 (0-14.0)
60-69 11.6 (0-27.5) 11.2 (1.3-31.9) 10.7 (0-27.8) 11.1 (0-28.7) 11.6 (0-27.9)
70-79 26.2 (0-61.3) 26.1 (3.0-61.7) 25.6 (4.9-53.7) 25.9 (0-61.4) 25.2 (4.1-54.3)
  Coronary-revascularisation/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 1.26 (0-8.00) 1.32 (0-6.17) 1.34 (0-12.9) 1.34 (0-6.30) 1.45 (0-8.10)
50-59 4.00 (0-14.7) 4.27 (0-27.0) 4.41 (0-15.5) 5.14 (0-20.4) 5.21 (0-14.5)
60-69 7.55 (0-19.6) 8.02 (0-24.2) 8.35 (0-20.67) 9.25 (0-32.5) 10.0 (0-26.4)
70-79 8.74 (0-28.5) 9.22 (0-32.5) 9.65 (0-31.9) 10.9 (0-35.6) 11.8 (0-32.5)
  1. Utilisation of statins expressed as Defined Daily Doses per 1000 Inhabitants and Day (DDD/TID).
  2. 1 Mean (range)